FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2602965585> ?p ?o ?g. }

• W2602965585 endingPage "948" @default.
• W2602965585 startingPage "937" @default.
• W2602965585 abstract "BackgroundOsteoporotic fractures are associated with high morbidity, mortality, and cost.MethodsWe performed a post hoc analysis of the Women's Health Initiative (WHI) clinical trials data to assess osteoporosis treatment and identify participant characteristics associated with utilization of osteoporosis medication(s) after new diagnoses of osteoporosis or fracture. Information from visits prior to and immediately subsequent to the first fracture event or osteoporosis diagnosis were evaluated for medication use. A full logistic regression model was used to identify factors predictive of osteoporosis medication use after a fracture or a diagnosis of osteoporosis.ResultsThe median length of follow-up from enrollment to the last WHI clinic visit for the study cohort was 13.9 years. Among the 13,990 women who reported new diagnoses of osteoporosis or fracture between enrollment and their final WHI visit, and also had medication data available, 21.6% reported taking an osteoporosis medication other than estrogen. Higher daily calcium intake, diagnosis of osteoporosis alone or both osteoporosis and fracture (compared with diagnosis of fracture alone), Asian or Pacific Islander race/ethnicity (compared with White/Caucasian), higher income, and hormone therapy use (past or present) were associated with significantly higher likelihood of osteoporosis pharmacotherapy. Women with Black/African American race/ethnicity (compared with White/Caucasian), body mass index ≥30 (compared with body mass index of 18.5-24.9), current tobacco use (compared with past use or lifetime nonusers), and history of arthritis were less likely to use osteoporosis treatment.ConclusionDespite well-established treatment guidelines in postmenopausal women with osteoporosis or history of fractures, pharmacotherapy use was suboptimal in this study. Initiation of osteoporosis treatment after fragility fracture may represent an opportunity to improve later outcomes in these high-risk women. Specific attention needs to be paid to increasing treatment among women with fragility fractures, obesity, current tobacco use, history of arthritis, or of Black race/ethnicity." @default.
• W2602965585 created "2017-04-07" @default.
• W2602965585 creator A5007972753 @default.
• W2602965585 creator A5014971710 @default.
• W2602965585 creator A5016111941 @default.
• W2602965585 creator A5033029879 @default.
• W2602965585 creator A5036194463 @default.
• W2602965585 creator A5043936869 @default.
• W2602965585 creator A5051749869 @default.
• W2602965585 creator A5053051179 @default.
• W2602965585 creator A5054575797 @default.
• W2602965585 creator A5074440435 @default.
• W2602965585 creator A5075126581 @default.
• W2602965585 creator A5080121245 @default.
• W2602965585 date "2017-08-01" @default.
• W2602965585 modified "2023-10-17" @default.
• W2602965585 title "Osteoporosis in the Women's Health Initiative: Another Treatment Gap?" @default.
• W2602965585 cites W1042064430 @default.
• W2602965585 cites W1511797896 @default.
• W2602965585 cites W1554297622 @default.
• W2602965585 cites W1648069661 @default.
• W2602965585 cites W1961687835 @default.
• W2602965585 cites W1964880956 @default.
• W2602965585 cites W1965189531 @default.
• W2602965585 cites W1971089875 @default.
• W2602965585 cites W1971994696 @default.
• W2602965585 cites W1974737882 @default.
• W2602965585 cites W1974995152 @default.
• W2602965585 cites W1982942836 @default.
• W2602965585 cites W1983005897 @default.
• W2602965585 cites W2002180930 @default.
• W2602965585 cites W2002557904 @default.
• W2602965585 cites W2005298224 @default.
• W2602965585 cites W2016253728 @default.
• W2602965585 cites W2018531724 @default.
• W2602965585 cites W2025438791 @default.
• W2602965585 cites W2026923058 @default.
• W2602965585 cites W2034892046 @default.
• W2602965585 cites W2035180720 @default.
• W2602965585 cites W2049843989 @default.
• W2602965585 cites W2055426452 @default.
• W2602965585 cites W2066195307 @default.
• W2602965585 cites W2087497728 @default.
• W2602965585 cites W2099054178 @default.
• W2602965585 cites W2105592972 @default.
• W2602965585 cites W2106286936 @default.
• W2602965585 cites W2107049851 @default.
• W2602965585 cites W2110396808 @default.
• W2602965585 cites W2114976199 @default.
• W2602965585 cites W2123214024 @default.
• W2602965585 cites W2124527463 @default.
• W2602965585 cites W2138163136 @default.
• W2602965585 cites W2146235472 @default.
• W2602965585 cites W2153009489 @default.
• W2602965585 cites W2161837912 @default.
• W2602965585 cites W2163830908 @default.
• W2602965585 cites W2164224167 @default.
• W2602965585 cites W2166969772 @default.
• W2602965585 cites W2167395179 @default.
• W2602965585 cites W2290627980 @default.
• W2602965585 cites W2296038563 @default.
• W2602965585 cites W2599286688 @default.
• W2602965585 doi "https://doi.org/10.1016/j.amjmed.2017.02.042" @default.
• W2602965585 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28366425" @default.
• W2602965585 hasPublicationYear "2017" @default.
• W2602965585 type Work @default.
• W2602965585 sameAs 2602965585 @default.
• W2602965585 citedByCount "25" @default.
• W2602965585 countsByYear W26029655852018 @default.
• W2602965585 countsByYear W26029655852019 @default.
• W2602965585 countsByYear W26029655852020 @default.
• W2602965585 countsByYear W26029655852021 @default.
• W2602965585 countsByYear W26029655852022 @default.
• W2602965585 crossrefType "journal-article" @default.
• W2602965585 hasAuthorship W2602965585A5007972753 @default.
• W2602965585 hasAuthorship W2602965585A5014971710 @default.
• W2602965585 hasAuthorship W2602965585A5016111941 @default.
• W2602965585 hasAuthorship W2602965585A5033029879 @default.
• W2602965585 hasAuthorship W2602965585A5036194463 @default.
• W2602965585 hasAuthorship W2602965585A5043936869 @default.
• W2602965585 hasAuthorship W2602965585A5051749869 @default.
• W2602965585 hasAuthorship W2602965585A5053051179 @default.
• W2602965585 hasAuthorship W2602965585A5054575797 @default.
• W2602965585 hasAuthorship W2602965585A5074440435 @default.
• W2602965585 hasAuthorship W2602965585A5075126581 @default.
• W2602965585 hasAuthorship W2602965585A5080121245 @default.
• W2602965585 hasBestOaLocation W26029655851 @default.
• W2602965585 hasConcept C126322002 @default.
• W2602965585 hasConcept C1862650 @default.
• W2602965585 hasConcept C187212893 @default.
• W2602965585 hasConcept C2776541429 @default.
• W2602965585 hasConcept C2780221984 @default.
• W2602965585 hasConcept C71924100 @default.
• W2602965585 hasConcept C72563966 @default.
• W2602965585 hasConceptScore W2602965585C126322002 @default.
• W2602965585 hasConceptScore W2602965585C1862650 @default.
• W2602965585 hasConceptScore W2602965585C187212893 @default.
• W2602965585 hasConceptScore W2602965585C2776541429 @default.

• next